Details for 2012722057

Up to date per 03.04.2026

Actions

Title / Product Name

RSV-F-PRÄFUSIONSANTIGENE

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2012722057

EP Publication Number

2707385

E-Number

930029

Language

PCT Number

US12037773

Publication Date

19.03.2014 A

20.09.2017 B1

Registration Date

20.09.2017

AT Publication Date

15.10.2017

Application Date

14.05.2012

Registration Number

Priorities

13.05.2011

201161486005 P

IPC

C07K 14/135 20060101AFI20121207BHEP

Maximum Duration of Protection

14.05.2032

Owner

GlaxoSmithKline Biologicals SARue de l'Institut 89 1330 RixensartBE

Representative

SONN Patentanwälte GmbH & Co KGRiemergasse 141010 WienAT

Inventor

SWANSON, Kurtc/o Novartis Vaccines And Diagonstics Inc. P.O. Box 8097 Emeryville, CA 94662-8097US

CARFI, Andreac/o Novartis Vaccines And Diagonstics Inc. P.O. Box 8097 Emeryville, CA 94662-8097US

Information about Fees